Research On Audit Risk Of Listed Companies Of Pharmaceutical Manufacturing In China

With the continuous development and progress of society,people's pursuit of health has reached an unprecedented height.At the same time,the share of pharmaceutical manufacturing industry is also gradually increasing,which has become an indispensable part of our national economy.In recent years,the country has paid more and more attention to the pharmaceutical manufacturing industry.A series of measures have been successively introduced,including encouraging the listing,consistency evaluation,two vote system,purchasing with quantity,etc.,which has also brought the pharmaceutical manufacturing enterprises into a new crossroads.However,in order to meet the expectations of investors and get more capital,some pharmaceutical manufacturing enterprises have repeatedly made articles on the financial statements,making the quality of relevant accounting information unsatisfactory,and the accompanying audit failure cases often occur.In view of this,this paper first summarizes the literature related to audit risk,and defines the relevant concepts and theoretical basis;secondly,according to the current policy of China,it makes a basic analysis of the particularity and audit risk of China's medical and pharmaceutical manufacturing industry;thirdly,based on the theoretical analysis,it puts forward the hypothesis,and takes 2 of the pharmaceutical manufacturing enterprises listed in Shanghai and Shenzhen From 2014 to 2018,881 audit opinion reports were taken as the research objects,and logistic regression analysis was carried out to study the influence of audit subject,audit object and audit environment on audit risk and the relationship between each factor and audit risk.In addition,Zixin pharmaceutical was introduced as a case company to further supplement and explain the empirical results and further explore the influencing factors of audit risk After that,according to the influencing factors of the audit risk of pharmaceutical manufacturing listed companies,the paper puts forward some suggestions on the audit risk control of pharmaceutical manufacturing listed companies.Through empirical research,this paper concludes that there are three main factors influencing the audit risk of pharmaceutical manufacturing listed companies.In the aspect of audit subject,the main factors influencing the audit risk are the type of audit opinions and audit fees of the previous year;in the aspect of audit object,the main factors influencing the audit risk are the proportion of the largest shareholder,the scale of the board of directors,the proportion of independent directors In terms of audit environment,there is a significant positive correlation between negative network opinion and audit risk.Here,crawler and python are used to collect data related to negative network opinion.Finally,based on the case and empirical analysis results,this paper puts forward some practical countermeasures to reduce audit risk from the perspectives of audit subject,audit object,legal environment of certified public accountant and supervision power of public opinion,so as to help the audit work of pharmaceutical manufacturing listed companies gradually improve.